The global separation system for commercial biotechnology market size is expected to reach USD 40.55 billion by 2030, expanding at a CAGR of 6.8% from 2024 to 2030. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.
Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for the production of food & cosmetics, agriculture, plastics, and chemicals.
Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand for potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.
Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.
This product will be delivered within 2 business days.
Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for the production of food & cosmetics, agriculture, plastics, and chemicals.
Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand for potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.
Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.
Separation Systems For Commercial Biotechnology Market Report Highlights
- Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment.
- However, modern methods are anticipated to grow at the fastest pace in the coming years due to the rise in adoption of these technologies.
- Technological advancements in product capabilities are anticipated to boost the separation systems for commercial biotechnology market.
- Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics.
- Rising prevalence of various chronic disorders is indirectly boosting growth.
- North America dominated the market with adequate administrative support, extensive research, and well-established industrial framework.
- Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support.
- Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems.
The leading players in the Separation Systems for Commercial Biotechnology market include:
- Thermo Fisher Scientific Inc.
- QIAGEN
- Horizon Discovery Ltd.
- OriGene Technologies, Inc.
- Oxford Biomedica PLC
- SignaGen Laboratories
- Flash Therapeutics
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- System Biosciences, LLC.
- Promega Corporation
- F. Hoffmann-La Roche Ltd
- Revvity
- Catalent, Inc
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Separation Systems for Commercial Biotechnology Market Variables, Trends, & Scope
Chapter 4. Separation Systems for Commercial Biotechnology Market: Method Estimates & Trend Analysis
Chapter 5. Separation Systems for Commercial Biotechnology Market: Application Estimates & Trend Analysis
Chapter 6. Separation Systems for Commercial Biotechnology Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
The leading players in the Separation Systems for Commercial Biotechnology market include:- Thermo Fisher Scientific Inc.
- QIAGEN
- Horizon Discovery Ltd.
- OriGene Technologies, Inc.
- Oxford Biomedica PLC
- SignaGen Laboratories
- Flash Therapeutics
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- System Biosciences, LLC.
- Promega Corporation
- F. Hoffmann-La Roche Ltd
- Revvity
- Catalent, Inc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 25.6 Billion |
| Forecasted Market Value ( USD | $ 40.55 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
